Trinidad and Tobago
Tuberculosis profile
| High HIV burden |
Population  2013 1.3 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.029 (0.024–0.036) 2.2 (1.8–2.7)
Mortality (HIV+TB only) <0.01 (<0.01–0.013) 0.67 (0.43–0.96)
Prevalence  (includes HIV+TB) 0.28 (0.12–0.51) 21 (8.6–38)
Incidence  (includes HIV+TB) 0.28 (0.26–0.31) 21 (20–23)
Incidence (HIV+TB only) 0.074 (0.069–0.081) 5.5 (5.1–6.1)
Case detection, all forms (%) 90 (80–95)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 1.7 (0.9–2.6) 13 (11–15)
MDR-TB cases among notified pulmonary
TB cases
4 (2–6) 5 (4–6)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 138   7
Pulmonary, clinically diagnosed 87   0
Extrapulmonary 18   0
       
Total new and relapse 250    
Previously treated, excluding relapses 30    
Total cases notified 280    
Among 250 new and relapse cases:
13 (5%) cases aged under 15 years; male:female ratio: 3.5
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 22 (16%) 17 (46%) 40
Laboratory-confirmed RR-/MDR-TB cases     13
Patients started on MDR-TB treatment     14
TB/HIV 2013 Number (%)
TB patients with known HIV status 265 (95)
HIV-positive TB patients 56 (21)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 9 (16)
HIV-positive TB patients on antiretroviral therapy (ART) 3 (5)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 63
Previously treated cases, excluding relapse, registered in 2012 37
HIV-positive TB cases, all types, registered in 2012 46
RR-/MDR-TB cases started on second-line treatment in 2011  
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in and outside
country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-04-27 Data: www.who.int/tb/data